Paper42985536PubMed
Integrated management of acute pulmonary embolism and the post-pulmonary embolism syndrome: risk stratification, modern therapies, and long-term follow-up.
Craciun ML and 8 others. Front Cardiovasc Med, 2026.
Cite this record
ConductScience Library. Integrated management of acute pulmonary embolism and the post-pulmonary embolism syndrome: risk stratification, modern therapies, and long-term follow-up. Papers, record 42985536. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42985536
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrated management of acute pulmonary embolism and the post-pulmonary embolism syndrome: risk stratification, modern therapies, and long-term follow-up.
- Journal
- Front Cardiovasc Med
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-06
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41712677 | 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2026 | https://conductscience.org/library/papers/41712677 | PubMed |
| 2 | 32223112 | Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32223112 | PubMed |
| 3 | 27932051 | Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study. | Chest | 2017 | https://conductscience.org/library/papers/27932051 | PubMed |
| 4 | 39566820 | Catheter-directed interventions in acute pulmonary embolism. Position statement of SEC-Interventional Cardiology Association/SEC-Ischemic Heart Disease and Acute Cardiovascular Care Association/SEC-Working Group on Pulmonary Hypertension. | Rev Esp Cardiol (Engl Ed) | 2025 | https://conductscience.org/library/papers/39566820 | PubMed |
| 5 | 19966341 | Dabigatran versus warfarin in the treatment of acute venous thromboembolism. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19966341 | PubMed |
| 6 | 20696966 | Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. | Arch Intern Med | 2010 | https://conductscience.org/library/papers/20696966 | PubMed |
| 7 | 37847768 | Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. | Circ Cardiovasc Interv | 2023 | https://conductscience.org/library/papers/37847768 | PubMed |
| 8 | 40023651 | Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial. | Lancet | 2025 | https://conductscience.org/library/papers/40023651 | PubMed |
| 9 | 34807722 | Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. | Ann Intern Med | 2022 | https://conductscience.org/library/papers/34807722 | PubMed |
| 10 | 21703676 | Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. | Lancet | 2011 | https://conductscience.org/library/papers/21703676 | PubMed |
| 11 | 28232411 | Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. | Eur Respir J | 2017 | https://conductscience.org/library/papers/28232411 | PubMed |
| 12 | 28335835 | Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28335835 | PubMed |
| 13 | 40590243 | Key elements of follow-up care after acute pulmonary embolism focusing on long-term sequelae: a Delphi study among European experts. | Eur Heart J Qual Care Clin Outcomes | 2025 | https://conductscience.org/library/papers/40590243 | PubMed |
| 14 | 15163775 | Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15163775 | PubMed |
| 15 | 29746227 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29746227 | PubMed |
| 16 | 34560806 | Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. | Thromb Haemost | 2022 | https://conductscience.org/library/papers/34560806 | PubMed |
| 17 | 33454291 | Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial. | JACC Cardiovasc Interv | 2021 | https://conductscience.org/library/papers/33454291 | PubMed |
| 18 | 34363386 | Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. | Eur Heart J | 2021 | https://conductscience.org/library/papers/34363386 | PubMed |
| 19 | 36349702 | Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. | EuroIntervention | 2023 | https://conductscience.org/library/papers/36349702 | PubMed |
| 20 | 38936968 | Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study. | Eur Respir J | 2024 | https://conductscience.org/library/papers/38936968 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42985536
GET https://conductscience.org/api/papers/v1/42985536/references?page=2